After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Demis Hassabis, CEO of Google DeepMind, hinted Tuesday evening that Veo 3, Google’s latest video generating model, could ...

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...

Sir Demis Hassabis said it feels like a recognition that AI is mature enough now to help with scientific discovery. Read more at straitstimes.com. Read more at straitstimes.com.

Meanwhile, tech giants like Amazon and Microsoft are slashing their workforce amid massive spending to build and deploy new ...

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...

We and our 911 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting I Accept enables tracking technologies to support the purposes shown under ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Demis Hassabis, DeepMind's founder and chief executive, has taken the same roles at Isomorphic Labs on an interim basis, saying in a blog post that the new company will "reimagine the entire drug ...